By Osman Shabir, M.Sc. | Reviewed by Dr. Jennifer Logan, MD, MPH Parkinson’s disease is a neurodegenerative disorder clinically characterized by dyskinesia (impairment of movement), resting tremor, bradykinesia (slow movements), dystonia (stiffness of muscles including facial muscles), a stooped posture, drooling, sexual and urinary dysfunction, and in some cases psychiatric symptoms including psychosis, dementia, and depression....
Category: <span>parkinsons</span>
Post
New insights into how immune system and inflammation play a role in PD
Reviewed by Kate Anderton, B.Sc. (Editor) Relatively new research findings indicating that the earliest stages of Parkinson’s disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of Parkinson’s Disease, Tomasz Brudek, PhD, evaluates evidence for the association between inflammatory bowel disease (IBD) and...
Post
Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?
Scientists review the evidence for using fecal transplantation and pre- and probiotics in patients with Parkinson’s disease in the Journal of Parkinson’s Disease IOS PRESS Amsterdam, NL, November 15, 2019 – Constipation is a common complaint in patients with Parkinson’s disease (PD). Fecal microbiome transplantation (FMT) and pre- and probiotics are potential options for treating...
Post
Researchers discover a way to turn Parkinson protein on itself
This news or article is intended for readers with certain scientific or professional knowledge in the field. Researchers have found a way to create a super-inhibitor that effectively stops the development of Parkinsons by using the Parkinson disease itself as an active building block. Various neurodegenerative diseases such as Parkinson’s are closely linked to the...
Post
Researchers report new insights into Parkinson’s disease-related mortality
by IOS Press By following a group of newly diagnosed patients with Parkinson’s disease (PD) for a decade or more, researchers have been able to identify several factors never before reported that appear to be associated with higher mortality rates in PD patients compared to the general population. As reported in the Journal of Parkinson’s...
Post
Discovery may help derail Parkinson’s ‘runaway train’
Researchers have discovered a new enzyme that inhibits the LRRK2 pathway, the most common cause of genetic Parkinson’s UNIVERSITY OF DUNDEE Researchers at the University of Dundee have made a discovery they believe has the potential to put the brakes on the ‘runaway train’ that is Parkinson’s disease. The team, based at the Medical Research...
Post
Parkinson’s disease is also present in the blood
by Aarhus University The behaviour of immune cells in the blood is so different in patients with Parkinson’s disease that it advocates for a new type of supplementary medicine, which can regulate the immune system and thus inhibit the deterioration of the brain. These are the perspectives in a new study which researchers from the...
Post
Genetic markers linked to the start of symptoms of Parkinson’s disease
by University of Barcelona Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro), Hospital Clínic and the IDIBAPS have identified a group of genetic variants related to the starting point of Parkinson’s disease Credit: University of Barcelona – UBNeuro Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro), Hospital...
Post
Genetic markers linked to the start of symptoms of Parkinson’s disease
by University of Barcelona Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro), Hospital Clínic and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) have identified a group of genetic variants related to the starting point of Parkinson’s disease. These results, published in the journal Movement Disorders, will enable delimiting the research on new therapeutic targets, and...
Post
Scientists listed ways of applying genetic engineering to treat Parkinson’s disease
How CRISPR can help fight against neurodegenerative diseases SECHENOV UNIVERSITY Researchers of Sechenov University and University of Pittsburgh described the most promising strategies in applying genetic engineering for studying and treating Parkinson’s disease. This method can help evaluate the role of various cellular processes in pathology progression, develop new drugs and therapies, and estimate their...